Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Assets Average: 2011-2025

Historic Assets Average for Niagen Bioscience (NAGE) over the last 7 years, with Sep 2025 value amounting to $94.8 million.

  • Niagen Bioscience's Assets Average rose 71.55% to $94.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.8 million, marking a year-over-year increase of 71.55%. This contributed to the annual value of $61.6 million for FY2024, which is 13.04% up from last year.
  • Latest data reveals that Niagen Bioscience reported Assets Average of $94.8 million as of Q3 2025, which was up 9.72% from $86.4 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Assets Average registered a high of $94.8 million during Q3 2025, and its lowest value of $46.1 million during Q3 2022.
  • Its 3-year average for Assets Average is $63.4 million, with a median of $54.5 million in 2024.
  • Its Assets Average has fluctuated over the past 5 years, first fell by 26.93% in 2022, then spiked by 71.55% in 2025.
  • Over the past 5 years, Niagen Bioscience's Assets Average (Quarterly) stood at $59.1 million in 2021, then fell by 15.70% to $49.9 million in 2022, then rose by 8.75% to $54.2 million in 2023, then increased by 15.08% to $62.4 million in 2024, then skyrocketed by 71.55% to $94.8 million in 2025.
  • Its Assets Average stands at $94.8 million for Q3 2025, versus $86.4 million for Q2 2025 and $74.8 million for Q1 2025.